MSCI (MSCI) recently caught investors’ attention after its performance over the past month saw shares rise by nearly 3%. With steady annual revenue and net income growth, many are watching to see whether this momentum will continue.
See…
Category: 6. Business
-
More than 1,000 flights cancelled as US air traffic cuts enter second day
Getty ImagesTravellers wait in a long line at a security checkpoint at Houston’s George Bush Intercontinental Airport on 6 November More than 1,000 flights to, from, or within the US were cancelled on Saturday after airlines were told this week to…
Continue Reading
-
Chan Breaks Down the Need for Dose Escalation With Somatostatin Analogs in GEP-NETs
Pending the results of the ongoing phase 3 SORENTO trial (NCT05050942), increasing the dose or shortening the treatment interval of somatostatin analogs may be a viable route to take for patients with gastroenteropancreatic neuroendocrine tumors…
Continue Reading
-
Evaluating Valuation After Recent Share Price Pullback
ACI Worldwide (ACIW) shares moved lower after the company’s latest trading session, closing down 3% to $48.96. While the decline caught some attention, it follows an otherwise resilient performance over the past month.
See our latest…
Continue Reading
-
JFrog (FROG) Is Up 26.4% After Surpassing Q3 Estimates and Lifting Full-Year Cloud Outlook
-
JFrog has reported third-quarter results that exceeded analyst expectations, highlighted by a record US$136.91 million in revenue and a 50% year-over-year increase in cloud revenue, with the company also raising its outlook for the fourth…
Continue Reading
-
-
A crisis at chipmaker Nexperia sent automakers scrambling. Here’s what to know
A battle for control of a little-known chipmaker has threatened global auto production by choking off the semiconductor supply chain, though there are signs the crisis is inching toward a resolution.
The power struggle over Nexperia, a…
Continue Reading
-
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
Enlicitide, designed to deliver antibody-like efficacy, has the potential to be the first approved oral PCSK9 inhibitor to lower LDL-C with a safety profile comparable to placebo
Enlicitide may help address unmet needs in ASCVD, a key…
Continue Reading
-
Fish Oil Shows Cardiovascular Benefits in Dialysis Patients – Medscape
- Fish Oil Shows Cardiovascular Benefits in Dialysis Patients Medscape
- Fish oil supplementation may reduce CVD risks for people on dialysis Healio
- Fish Oil Cuts Risk of Serious Heart Events in Dialysis Patients MedPage Today
- PISCES: Fish Oil…
Continue Reading
-
ABC chair warns ‘extremely autocratic’ views of some AI investors could lead to ‘dangerous and sinister’ outcomes | Australian Broadcasting Corporation
The chair of the ABC has warned that AI could become “dangerous and sinister” considering some who finance it hold views that are “extremely autocratic”.
Kim Williams, who has been chair of the national broadcaster since March 2024, is a…
Continue Reading
-
A crisis at chipmaker Nexperia sent automakers scrambling. Here’s what to know
A battle for control of a little-known chipmaker has threatened global auto production by choking off the semiconductor supply chain, though there are signs the crisis is inching toward a resolution.
The power struggle over Nexperia, a…
Continue Reading
